Last reviewed · How we verify
Prevention of Neonatal Ophthalmia
Approved treatments
- E-Mycin · Generic (originally Abbott/Lilly)
- Benzamycin · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of Neonatal Ophthalmia patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of Neonatal Ophthalmia treatment landscape brief
- Prevention of Neonatal Ophthalmia treatment updates RSS
Frequently asked questions about Prevention of Neonatal Ophthalmia
What drugs treat Prevention of Neonatal Ophthalmia?
Tracked treatments include E-Mycin, Benzamycin.
What is the treatment for Prevention of Neonatal Ophthalmia?
Standard treatment for Prevention of Neonatal Ophthalmia includes E-Mycin, Benzamycin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of Neonatal Ophthalmia patent cliff · Prevention of Neonatal Ophthalmia CI report
- Treatment: E-Mycin · Generic (originally Abbott/Lilly)
- Treatment: Benzamycin · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing